LEAP2 Regulates Insulin Secretion from INS-1E Beta Cells and Rat Pancreatic Islets: An In Vitro Study
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177536 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Oskar Sosiński und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Wolynska 35, 60-637 Poznan, Poland. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Insulin Secretion, Insulin, Islets of Langerhans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.
Abstract (Originalsprache)
LEAP2 is an endogenous antagonist and inverse agonist of GHSR-1a, the receptor for acyl-ghrelin. Although LEAP2 is increasingly recognized as a regulator of appetite and glucose homeostasis, its direct effects on pancreatic endocrine cells remain incompletely understood. The present in vitro study evaluated whether LEAP2 modulates insulin secretion and the expression of insulin-related genes in INS-1E beta cells and isolated rat pancreatic islets. LEAP2 treatment altered selected components of the insulin-related expression profile in a model- and time-dependent manner. In INS-1E cells, LEAP2 increased insulin protein expression after 6 h and IRSII protein expression after 24 h, whereas effects on mRNA expression were variable. In isolated rat islets, LEAP2 increased INS2 mRNA expression and decreased GHSR-1a and preproghrelin mRNA expression under the tested conditions. Acute exposure to 100 nM LEAP2 increased basal insulin release from both INS-1E cells and isolated islets. Immunofluorescence and Western blot analyses detected LEAP2- and GHSR-1a-related immunoreactivity in pancreatic models. LEAP2 did not adversely affect INS-1E cell metabolic activity, proliferation, or apoptosis. Overall, these data suggest that LEAP2 can modulate pancreatic endocrine cell function under in vitro conditions, but further studies using standard glucose-stimulated insulin secretion protocols and in vivo models are required to define its physiological relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Wolynska 35, 60-637 Poznan, Poland.
- Department of Genetics and Animal Breeding, Poznan University of Life Sciences, Wolynska 33, 60-637 Poznan, Poland.
ORCID-Profile: Ewa Pruszyńska-Oszmałek, Natalia Leciejewska, Piotr Pawlak, Paweł Antoni Kołodziejski
Förderung
- National Science Centre
Zitieren
APA
Sosiński, O., Pruszyńska-Oszmałek, E., Sassek, M., Leciejewska, N., Pawlak, P., & Kołodziejski, P. A. (2026). LEAP2 Regulates Insulin Secretion from INS-1E Beta Cells and Rat Pancreatic Islets: An In Vitro Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177536
Vancouver
Sosiński O, Pruszyńska-Oszmałek E, Sassek M, Leciejewska N, Pawlak P, Kołodziejski PA. LEAP2 Regulates Insulin Secretion from INS-1E Beta Cells and Rat Pancreatic Islets: An In Vitro Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177536
BibTeX
@article{Sosiski2026,
author = {Sosiński, Oskar and Pruszyńska-Oszmałek, Ewa and Sassek, Maciej and Leciejewska, Natalia and Pawlak, Piotr and Kołodziejski, Paweł Antoni},
title = {LEAP2 Regulates Insulin Secretion from INS-1E Beta Cells and Rat Pancreatic Islets: An In Vitro Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177536}
}
EUVIMED